Ron Branning joins Genzyme

pharmafile | January 14, 2010 | Appointment | Manufacturing and Production |  Genzyme, appointment, manufacturing and production 

Genzyme has appointed industry veteran Ron Branning as its new senior vice president of global product quality.

Branning has 30 years’ experience working at the likes of Johnson & Johnson, Genentech and Gilead Sciences, and will have the task of getting Genzyme’s manufacturing back on track after a series of quality issues at its Allston Landing facility.

Genzyme chief executive Henri Termeer said: “Bringing in new senior leaders such as Ron is a fundamental component of our plan to renew and strengthen our manufacturing organisation.”

Advertisement

In his new role Branning will be in charge of monitoring product quality across the company’s 17 sites around the world.

Related Content

Rotzinger launches modular filling and capping platform for over-the-counter products

Rotzinger PharmaPack has launched a new filling and capping platform called VarioFill, designed to handle …

David Wheadon appointed to board of directors at Seaport Therapeutics

This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

sarah_mcdonald

Myeloma UK reveals new Director of Research appointment

UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …

The Gateway to Local Adoption Series

Latest content